Peer Review reports
From: Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
| Original Submission | ||
|---|---|---|
| 13 Feb 2017 | Submitted | Original manuscript |
| 4 May 2017 | Reviewed | Reviewer Report - Andreas K Lauer |
| 27 May 2017 | Reviewed | Reviewer Report - Lyubomyr Lytvynchuk |
| 18 Jun 2017 | Author responded | Author comments - Joel Hanhart |
| Resubmission - Version 2 | ||
| 18 Jun 2017 | Submitted | Manuscript version 2 |
| 24 Sep 2017 | Author responded | Author comments - Joel Hanhart |
| Resubmission - Version 3 | ||
| 24 Sep 2017 | Submitted | Manuscript version 3 |
| Publishing | ||
| 3 Oct 2017 | Editorially accepted | |
| 10 Oct 2017 | Article published | 10.1186/s12886-017-0586-0 |
You can find further information about peer review here.